Brief: Lidds AB - Nmpa Has Extended Requirements To A Full Registration Dossier For Conditional Market Approval

Lidds AB

18/12/2020 07:40

Dec 18 (Reuters) - Lidds AB  LIDDS.ST :
    * LIDDS AB - NMPA HAS EXTENDED REQUIREMENTS TO A FULL REGISTRATION DOSSIER FOR CONDITIONAL
MARKET
APPROVAL (CMA)
    * LIDDS AB - LIDDS LICENSEE JIANGXI PUHENG PHARMA IS THEREFORE AIMING TO SUBMIT APPLICATION
FOR
CMA FOR PROSTATE CANCER DRUG CANDIDATE LIPROCA® DEPOT IN CHINA DURING Q1, 2021

Source text for Eikon:  ID:nGNE4Ntp66 
Further company coverage:  LIDDS.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))